Integra LifeSciences Holdings Corporation (IART)
NASDAQ · Healthcare
Integra LifeSciences Holdings Corporation Long Term Debt 2016–2025
Integra LifeSciences Holdings Corporation annual long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Integra LifeSciences Holdings Corporation long term debt as of December 31, 2025: 726.6M, a 4.46% decrease year-over-year.
- Integra LifeSciences Holdings Corporation long term debt for 2025 were 726.6M, a 4.46% decrease from 2024.
- Integra LifeSciences Holdings Corporation long term debt for 2024 were 760.5M, a 1.87% decrease from 2023.
- Integra LifeSciences Holdings Corporation long term debt for 2023 were 775.0M, a 0.00% increase from 2022.
- Integra LifeSciences Holdings Corporation long term debt for 2022 were 775.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Integra LifeSciences Holdings Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $727 |
| 2024 | $760 |
| 2023 | $775 |
| 2022 | $775 |
| 2021 | $844 |
| 2020 | $878 |
| 2019 | $878 |
| 2018 | $900 |
Integra LifeSciences Holdings Corporation Long Term Debt — FAQ
Integra LifeSciences Holdings Corporation (IART) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IART's long term debt history?
The chart and table above show Integra LifeSciences Holdings Corporation's long term debt by year and by quarter, including the growth rate.